Results 261 to 270 of about 1,073,230 (303)
Some of the next articles are maybe not open access.

The pharmacology of graft rejection

Trends in Pharmacological Sciences, 1979
Abstract Graft rejection is a complex reaction and although the immunology is well understood, the pharmacology of graft rejection is still in its early days. We have tried to review the pharmacological studies that are contributing towards a better understanding of this reaction.
G.P. Lewis, Beverley A. Mangham
openaire   +2 more sources

Prevention and Treatment of Corneal Graft Rejection: Current Practice Patterns of the Cornea Society (2011)

Cornea, 2015
Purpose: To analyze current practice patterns in the prevention and treatment of corneal graft rejection for both penetrating keratoplasty (PK) and endothelial keratoplasty (EK) and to compare these patterns with previously reported practices.
Bhairavi Kharod-Dholakia   +3 more
semanticscholar   +1 more source

Graft Rejection and Glaucoma

American Journal of Ophthalmology, 1986
Four patients (three women and one man, 30 to 63 years old) developed increased intraocular pressure during graft rejection reactions. The increased intraocular pressure returned to normal in one case after successful treatment of the immune reaction but a second patient required antiglaucoma medication for a short period.
openaire   +3 more sources

Placental hormones and graft rejection

American Journal of Obstetrics and Gynecology, 1969
Abstract To explore the possibility that the placenta prevents its own immunologic rejection by the mother by producing a “hormonal barrier” either locally or systemically, rabbits undergoing skin allograft exchanges were given placental hormones either systemically or at graft sites.
Jaroslav F. Hulka, Kathleen Mohr
openaire   +3 more sources

Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry.

Journal of Proteome Research, 2014
Acute graft rejection is one of the most common and serious postcomplications in renal transplantation. A noninvasive method is needed to specifically monitor acute graft rejection.
Xinjie Zhao   +3 more
semanticscholar   +1 more source

The Pattern of Corneal Graft Rejection

Cornea, 1990
A series of 160 consecutive penetrating keratoplasties was analysed for patterns of graft rejection. All surgery was performed between January 1981 and December 1987. The incidence of homograft rejection was 34% (54 grafts). The site of the initial rejection episode was analysed.
W. F.I. Shepherd, G. N. Kervick
openaire   +3 more sources

The Immunology of Corneal Graft Rejection

Critical Reviews™ in Immunology, 1998
Corneal transplantation is the most successful of organ transplants due to the fact that the eye is an immunologically privileged site, and the cornea is an immunologically privileged tissue. The factors responsible for this include presence of the blood-aqueous barrier, the avascularity of the cornea, the absence of classic antigen-presenting cells ...
Guillermo Rocha   +2 more
openaire   +3 more sources

A role for CD95 ligand in preventing graft rejection

Nature, 1995
TESTIS is a remarkable immune-privileged site, long known for its ability to support allogeneic and xenogeneic tissue transplants1á¤-4. Here we have investigated the molecular basis for testis immune privilege.
D. Bellgrau   +5 more
semanticscholar   +1 more source

Graft Rejection and Graft Failure After Penetrating Keratoplasty or Posterior Lamellar Keratoplasty for Fuchs Endothelial Dystrophy

Cornea, 2013
Purpose: To compare the frequency of rejection episodes and graft failure because of surgical complications or rejection after Descemet stripping automated endothelial keratoplasty (DSAEK) and penetrating keratoplasty (PK) for Fuchs endothelial dystrophy.
J. Hjortdal   +3 more
semanticscholar   +1 more source

Regulating Graft Rejection

Science, 2002
IMMUNOLOGY Achieving immune tolerance to transplanted tissues remains a major hurdle in organ transplantation. Increasingly, it is becoming clear that protocols aimed at improving graft-specific tolerance will need to consider regulatory T cells, because these lymphocytes are known to be important in suppressing immune responses. Graca et al.
openaire   +2 more sources

Home - About - Disclaimer - Privacy